NasdaqGS - Delayed Quote USD

Nasdaq, Inc. (NDAQ)

60.29 -1.21 (-1.97%)
At close: 4:00 PM EDT
60.19 -0.10 (-0.17%)
After hours: 6:37 PM EDT

Earnings Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 14141616
Avg. Estimate 0.650.682.793.14
Low Estimate 0.610.632.643.03
High Estimate 0.720.753.033.34
Year Ago EPS 0.690.712.822.79

Revenue Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 11111515
Avg. Estimate 1.11B1.14B4.65B4.97B
Low Estimate 1.09B1.1B4.52B4.77B
High Estimate 1.14B1.17B4.79B5.11B
Year Ago Sales 914M925M3.9B4.65B
Sales Growth (year/est) 21.80%23.10%19.30%6.90%

Earnings History

CURRENCY IN USD 3/31/2023 6/30/2023 9/30/2023 12/31/2023
EPS Est. 0.660.660.680.71
EPS Actual 0.690.710.710.72
Difference 0.030.050.030.01
Surprise % 4.50%7.60%4.40%1.40%

EPS Trend

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate 0.650.682.793.14
7 Days Ago 0.650.682.793.14
30 Days Ago 0.640.672.763.1
60 Days Ago 0.640.672.763.1
90 Days Ago 0.650.672.783.1

EPS Revisions

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days 7755
Down Last 7 Days --------
Down Last 30 Days 11--1

Growth Estimates

CURRENCY IN USD NDAQIndustrySectorS&P 500
Current Qtr. -5.80%----2.60%
Next Qtr. -4.20%----13.40%
Current Year -1.10%----5.20%
Next Year 12.50%----13.30%
Next 5 Years (per annum) 7.94%----11.11%
Past 5 Years (per annum) 13.53%------

Research Analysis

Analyst Price Targets

54.00 Low
66.60 Average
60.29 Current
82.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Upgrades & Downgrades

Initiated Barclays: Overweight 4/11/2024
Upgrade Morgan Stanley: Equal-Weight to Overweight 4/9/2024
Upgrade Goldman Sachs: Neutral to Buy 3/26/2024
Maintains Piper Sandler: Overweight to Overweight 2/1/2024
Maintains Oppenheimer: Outperform to Outperform 2/1/2024
Reiterates Rosenblatt: Buy to Buy 2/1/2024

Related Tickers